These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2881898)

  • 1. Interactions of dihydroergotamine with etilefrine in human leg veins in vitro and in situ.
    Barthel W; Glusa E; Koth W
    Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):63-9. PubMed ID: 2881898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydroergotamine: pharmacokinetics, pharmacodynamics, and mechanism of venoconstrictor action in beagle dogs.
    Müller-Schweinitzer E; Rosenthaler J
    J Cardiovasc Pharmacol; 1987 Jun; 9(6):686-93. PubMed ID: 2442535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental pharmacological studies of the venous tonus-modifying effect of dihydroergotamine].
    Glusa E
    Z Gesamte Inn Med; 1984 Sep; 39(17):414-7. PubMed ID: 6095548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interaction of dihydroergotamine and etilefrine-hydrochloride at capacitance vessels of the calf in man (author's transl)].
    Inoue H; Inoue K; Arndt JO
    Z Kardiol; 1980 Apr; 69(4):280-6. PubMed ID: 6109407
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacodynamics and pharmacokinetics of dihydroergotamine (DHE) in conscious beagle dogs.
    Müller-Schweinitzer E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):162-5. PubMed ID: 2459013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydroergotamine increases the bioavailability of orally administered etilefrine.
    Hengstmann JH; Hengstmann R; Schwonzen S; Dengler HJ
    Eur J Clin Pharmacol; 1982; 22(5):463-7. PubMed ID: 6126364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Venous tonus-modifying effect, pharmacokinetics and undesired effects of dihydroergotamine].
    Barthel W
    Z Gesamte Inn Med; 1984 Sep; 39(17):417-28. PubMed ID: 6390997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on 5-hydroxytryptamine receptors on isolated human femoral veins and arteries and the influence of dihydroergotamine.
    Glusa E; Markwardt F
    Pharmacology; 1984; 29(6):336-42. PubMed ID: 6505006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venoconstrictor responses to dihydroergocristine and dihydroergotamine: evidence for the involvement of 5-HT1 like receptors.
    Müller-Schweinitzer E
    Cardiovasc Drugs Ther; 1990 Dec; 4(6):1455-60. PubMed ID: 2127899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoconstrictor effect of midodrine, ST 1059, noradrenaline, etilefrine and dihydroergotamine on isolated human veins.
    Thulesius O; Gjöres JE; Berlin E
    Eur J Clin Pharmacol; 1979; 16(6):423-4. PubMed ID: 93544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual effect of dihydroergotamine and dihydroergotoxin in isolated human femoral veins and arteries.
    Glusa E; Markwardt F
    Pharmacology; 1982; 24(5):287-93. PubMed ID: 6285391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological actions of the main metabolites of dihydroergotamine.
    Müller-Schweinitzer E
    Eur J Clin Pharmacol; 1984; 26(6):699-705. PubMed ID: 6489409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo studies after oral treatment of the beagle with dihydroergotamine.
    Müller-Schweinitzer E; Rosenthaler J
    Eur J Pharmacol; 1983 Apr; 89(1-2):1-8. PubMed ID: 6861880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the pharmacology of venous smooth muscle from dog and man.
    Müller-Schweinitzer E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):690-704. PubMed ID: 94863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative plethysmographic study of the venoconstrictor effect of dihydroergotamine and dihydroergotoxine on the deep veins of the calf in healthy subjects and patients suffering from varicosis.
    Barthel W; Grossmann K
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):458-64. PubMed ID: 7141753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of dihydroergotamine (DHE) on blood volume and circulation in the calf in peridural anesthesia in the human].
    Stühmeier KD; Stanton-Hicks M; Arndt JO
    Reg Anaesth; 1987 Oct; 10(4):109-13. PubMed ID: 3685475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dihydroergotamine on leg blood flow during combined epidural and general anaesthesia and postoperative deep vein thrombosis after cholecystectomy.
    Hendolin H; Poikolainen E; Mattila MA; Alhava E; Hänninen A; Puttonen E; Kataja M
    Acta Anaesthesiol Scand; 1993 Apr; 37(3):288-95. PubMed ID: 8100105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of etilefrine and dihydroergotamine on sympathetic nervous system activity when standing up (author's transl)].
    Kaden F; Mäurer W; Schömig A; Spohr U
    Dtsch Med Wochenschr; 1978 Sep; 103(39):1513-7. PubMed ID: 28936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the venoconstrictor activity of dihydroergotamine and its pharmacokinetics during acute and chronic oral dosing.
    de Marées H; Welzel D; de Marées A; Klotz U; Tiedjen KU; Knaup G
    Eur J Clin Pharmacol; 1986; 30(6):685-9. PubMed ID: 3533566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods for studying drug effects on superficial human veins.
    Aellig WH
    Methods Find Exp Clin Pharmacol; 1985 Jun; 7(6):321-4. PubMed ID: 3840550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.